COVID-19 Vaccines in Patients With Chronic Liver Disease

Status Recruiting

Clinical Trial Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused pandemic since outbreak in 2020.Patients with chronic liver disease (CLD) are at higher risk of mortality and morbidity due to COVID-19. Despite there is a large number of clinical trials of COVID-19 vaccines, only a few participants with chronic liver diseases were included.

Clinical Trial Description

This study is a prospective, open-label clinical trial. A total of 300 patients with different cancers including chronic hepatitis, cirrhosis .All of the patients will further accept 18 months follow-up study after vaccination. Safety and immunogenicity will be carefully recorded and detected. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05017805
Study type	Interventional
Source	Beijing 302 Hospital
Contact
Status	Recruiting
Phase	N/A
Start date	August 15, 2021
Completion date	August 15, 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05998330` - LiverPAL: A Trial of Inpatient Palliative Care for Patients With Advanced Liver Disease	N/A
Completed	`NCT03459521` - Efficacy of HBVaxpro40© and Fendrix© in Patients With Chronic Liver Disease.	N/A
Completed	`NCT05729269` - Characterization of Gut Microbiota in Chronic Liver Disease With Decreased Muscle Mass
Not yet recruiting	`NCT05205954` - HepHospital: A Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease	N/A
Completed	`NCT03130608` - Inspiratory Muscle Training Post-Liver Transplant	N/A
Recruiting	`NCT06111859` - Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification	N/A
Not yet recruiting	`NCT05193201` - A Phase Ib Clinical Study for rhTPO in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease	Phase 1
Not yet recruiting	`NCT05062967` - Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease
Not yet recruiting	`NCT05956015` - Albumin Catabolic Rate Measured by a Stable Isotope	N/A
Active, not recruiting	`NCT04339725` - Gut Microbiota Metagenomics for Chronic Liver Disease